Successful management of congenital chylous ascites in a premature infant using somatostatin analogue.

Abstract

Congenital chylous ascites (CCA) is a rare disease defined as the accumulation of chylomicron-rich lymphatic fluid within the peritoneal cavity, resulting from maldevelopment of the intra-abdominal lymphatic system. Cases unresponsive to conservative treatment usually require surgical intervention. We report a case of CCA in a premature neonate, who was treated successfully with intravenous infusion of octreotide, a synthetic somatostatin analogue after failure to response to traditional supportive therapies.

• Authors: Yuefang Huang, Siqi Zhuang, Yijuan Li, Meina Liu, Huiqing Chen, Minlian Du
• Journal: Indian journal of pediatrics (Indian J Pediatr) Vol. 78 Issue 3 Pg. 345-7 (Mar 2011) ISSN: 0973-7693 [Electronic] India
• PMID: 20953848 (Publication Type: Case Reports, Journal Article)

Chemical References

• Gastrointestinal Agents
• Octreotide

Topics

• Chylous Ascites (congenital, diagnosis, drug therapy)
• Female
• Gastrointestinal Agents (administration & dosage, therapeutic use)
• Humans
• Infant, Newborn
• Infant, Premature
• Infant, Premature, Diseases (diagnosis, drug therapy)
• Infusions, Intravenous
• Octreotide (administration & dosage, therapeutic use)
• Treatment Outcome